Squarer Ron's Insider Trades & SAST Disclosures
Squarer Ron's most recent trade in Travere Therapeutics Inc was a trade of 19,500 Stock option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Squarer Ron.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 6,500 | 35,375 (0%) | 0% | 0 | Common Stock | |
| Adc Therapeutics SA | Ron Squarer | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 80,663 | - | 2.9 | 20,216 | Common Shares |
| Adc Therapeutics SA | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 87,658 | - | 0 | Common Shares | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 6,500 | 28,875 (0%) | 0% | 0 | Common Stock | |
| Deciphera Pharmaceuticals Inc | Squarer Ron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 4,727 | 4,727 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 3,269 | 3,269 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 9,000 | 9,000 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 3,000 | 17,875 (0%) | 0% | 0 | Common Stock | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 9,570 | 9,570 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 9,000 | 9,000 | - | - | Stock option (right to buy) | |
| Travere Therapeutics Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,000 | 14,875 (0%) | 0% | 0 | Common Stock | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,563 | 1,563 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2020 | 723 | 723 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges